Osteoarthritis and Bone Disorders News

Patients who receive tramadol for osteoarthritis demonstrate an increased risk for hip fractures, venous thromboembolism and mortality, compared with those treated with NSAIDs, according to data published in Arthritis Research and Therapy.

SAN DIEGO — Men with osteoporosis receiving daily injections of abaloparatide had greater increases in bone mineral density at the lumbar spine, total hip and femoral neck at 12 months compared with placebo, according to a speaker.

Postmenopausal women assigned denosumab have increases in mineral to matrix ratio at the cortical and cancellous bone at 2 to 3 years, but changes were not observed beyond 5 years, according to study findings.

The FDA has given 510(k) clearance for artificial intelligence software developed to support providers in the evaluation and assessment of musculoskeletal disease for older adults, according to an industry press release.

Orthofix Medical Inc. announced it received FDA pre-market approval for the AccelStim bone healing therapy class III device, which provides nonsurgical treatment for indicated fresh fractures and nonunions.

Tanezumab and NSAIDs both demonstrated early and sustained improvement in pain and function among patients with knee or hip osteoarthritis, according to data published in Arthritis Research and Therapy.

Patients with osteoarthritis who developed dementia were more likely than their counterparts without dementia to be hospitalized for ambulatory care services, according to a speaker at the 2022 OARSI World Congress.

The COVID-19 pandemic has wrecked “significant negative impacts” on pain, function and treatment accessibility for individuals with chronic musculoskeletal pain, according to a speaker at the 2022 OARSI World Congress.

High tibial osteotomy leading to large changes in knee dynamics may reduce the likelihood of total knee replacement in patients with knee osteoarthritis, according to a speaker at the 2022 OARSI World Congress.

Mechanical load plus a biomarker that reflects cartilage degradation may predict worsening cartilage thickness in knee osteoarthritis, according to a speaker at the 2021 OARSI World Congress.